2Zhao MH,Short AK.Lockwood CM.Antineutrophil cytoplsm autoantibodies and vasculitis.Curr opin Haematol,1995.2(1):96-102.
3Chen M,Yu F,Zhang Y,et al.Clinical[corrected] and pathological characteristics of Chinese patients with antineutrophil cytoplasmic autoantibody associated systemic vasculitides:a study of 426 patients from a single centre.Postgrad Med J,2005,81(961):723-727.
4Xin G,Zhao MH,Wang HY.Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis.Clin Diagn Lab lmmunol,2004,11(3):559-562.
5Wang Y,Zhao MH,Yu J,et al.The clinical and pathological characteristics of Chinese elderly patients with anti-neutrophil cytoplasmic autoantibodies associated Small vessel vasculitis.Exp Gerontol,2004,39(9):1401-1405.
6Watts RA.Scott DG.Epidemiology of the vasculitides.Curr Opin Rheumatol,2003,15(1):11-16.
7Hagen EC,Daha MR,Hermans J,et al.Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis.EC/BCR Project for ANCA Assay Standardization.Kidney Int,1998,53(3):743-753.
8Jennette JC,Falk RJ,Andrassy K,et al.Nomenclature of systemic vasculitides.Proposal of an international consensus conference.Arthritis Rheum,1994,37(2):187-192.
9Cuillevin L,Pagnoux C.Treatment of refractory and/or severe ANCA-associated systmic necrotizing vasculitides.Isr Med Assoc J.2008,10(1):89-91.
10Santana AN.Antunes T,Barbas.CS.Treatmemt of ANCA-associatedvasculitis.JAMA,2007,298(23):2739.
